The decreased percentage of BAFF-R+ B cells after RTX treatment, which was also found in patients with rheumatoid arthritis [28] may be due to a relative increase of memory-like B cells, which have lower or no BAFF-R expression [27]. The gene discussed is TNFRSF13C; the disease is rheumatoid arthritis.